0001209191-18-062117.txt : 20181211
0001209191-18-062117.hdr.sgml : 20181211
20181211194114
ACCESSION NUMBER: 0001209191-18-062117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181207
FILED AS OF DATE: 20181211
DATE AS OF CHANGE: 20181211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hindman James M.
CENTRAL INDEX KEY: 0001617615
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35890
FILM NUMBER: 181229854
MAIL ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Millendo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001544227
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 451472564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
BUSINESS PHONE: 734-845-9000
MAIL ADDRESS:
STREET 1: 301 NORTH MAIN STREET, SUITE 100
CITY: ANN ARBOR
STATE: MI
ZIP: 48104
FORMER COMPANY:
FORMER CONFORMED NAME: OvaScience, Inc.
DATE OF NAME CHANGE: 20120308
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-07
0
0001544227
Millendo Therapeutics, Inc.
MLND
0001617615
Hindman James M.
C/O MILLENDO THERAPEUTICS, INC.
301 N. MAIN ST., SUITE 100
ANN ARBOR
MI
48104
1
0
0
0
Stock Option (right to buy)
6.59
2018-12-07
4
A
0
17509
A
2026-08-09
Common Stock
17509
17509
D
Stock Option (right to buy)
16.40
2018-12-07
4
A
0
3720
A
2028-08-23
Common Stock
3720
3720
D
Twenty-five percent (25%) of the shares subject to the option vested on June 17, 2017, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Received in connection with the merger of Millendo Therapeutics, Inc. ("Millendo") into the Issuer (the "Merger") in exchange for a stock option to acquire 235,341 shares of Millendo common stock for $0.49 per share.
Twenty-five percent (25%) of the shares subject to the option shall vest on August 20, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Received in connection with the Merger in exchange for a stock option to acquire 50,000 shares of Millendo common stock for $1.22 per share.
/s/ Jeffery M. Brinza, Attorney-in-Fact
2018-12-11